Podcast: This Week in Managed Care—Responding to CMS and Other Health News

Every week, The American Journal of Managed Care^® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.

This week, the top managed care news included comments to several proposals from CMS; Medicare advocates say voters will be motivated by healthcare cost concerns during the midterm elections; research showed diabetes drug dapagliflozin, an SGLT2 inhibitor, reduces risks of major cardiovascular events.

Listen above or through one of these podcast services:

iTunes: http://apple.co/2eYWTss

TuneIn: http://bit.ly/2gv7iwj

Stitcher: http://bit.ly/2gCqtFg

Read more about the stories in this podcast:

Hospital Groups, Others Raise Concerns Over CMS Payment Proposal

Senate Votes 98-2 to Ban Pharmacist Gag Clauses

What We're Reading: Safety-Net Readmissions; Gag Clause Bill to Trump; CREATES Impact on Drug Spend

Medicare Advocates Call for Keeping Program as It Is, Cite Voter Concerns About Costs

Diabetes Drug Farxiga Cuts Heart Risks in Topline Results

CVD-REAL Results in More Diverse Countries Link SGLT2s to Lower Risk of Death, Heart Attack, Stroke